Naproxen for migraine
Naproxen is an NSAID used for acute migraine, although the US naproxen labels checked here do not list migraine among their indications. A Cochrane review found it better than placebo, and its authors questioned the clinical value of naproxen used alone.
On this page
What the labels say about migraine
Naproxen is an NSAID. Migraine is not listed on the naproxen labels opened for this page:
- Prescription tablets and oral suspension. Indications include arthritis conditions, tendonitis, bursitis, acute gout, pain and primary dysmenorrhea.
- Aleve (naproxen sodium), non-prescription. Uses include minor aches and pains, among them headache.
- Treximet. This prescription tablet combines sumatriptan with naproxen sodium and is indicated for acute migraine in adults and in patients 12 and older. Its boxed warning covers serious cardiovascular and gastrointestinal events. This page deals with naproxen alone.
Use for migraine outside a label’s indications is a decision for a prescriber. Doses come from the label or the prescriber. Approved uses differ by country.
Cochrane results at 2 hours
Law 2013 reviewed six studies: 1,241 participants took naproxen and 1,092 placebo. Results pool the two doses reviewed.
| Outcome at 2 hours | Naproxen | Placebo | Number needed to treat |
|---|---|---|---|
| Pain-free | 17% | 8% | 11 |
| Headache relief | 45% | 29% | 6.0 |
Adverse events, such as dizziness, sleepiness, nausea and indigestion, were mostly mild or moderate and rarely caused withdrawal. They were more common than with placebo in the pooled analysis, but not at the lower dose alone.
The authors found naproxen statistically superior to placebo. Because of the number needed to treat of 11, they concluded that it is not clinically useful as a stand-alone painkiller in acute migraine. This is a judgement about group results, not about any one person.
Boxed warning and contraindications
The prescription naproxen label carries a boxed warning for serious cardiovascular and gastrointestinal events: heart attack and stroke, and bleeding, ulceration and perforation that can be fatal and can occur without warning symptoms.
The label says naproxen must not be used:
- with known hypersensitivity to naproxen;
- with a history of asthma, urticaria or allergic-type reactions after aspirin or other NSAIDs;
- in the setting of coronary artery bypass graft surgery.
Further warnings cover liver and kidney toxicity, hypertension, heart failure, serious skin reactions and fetal toxicity. Listed interactions include anticoagulants, antiplatelet medicines, SSRIs and SNRIs, aspirin and other NSAIDs, ACE inhibitors, angiotensin receptor blockers, beta-blockers, diuretics, lithium and methotrexate.
The Aleve label says not to use it right before or after heart surgery. It tells people to ask a doctor first with high blood pressure, heart disease, kidney disease, liver cirrhosis or asthma, or when taking a diuretic, and to avoid use at 20 weeks or later of pregnancy unless a doctor directs it.
Monthly limit
ICHD-3 groups naproxen with the other non-opioid painkillers: 15 or more days a month for more than 3 months, and days with different medicines in this class add up. The medication days counter follows this rule.
In a headache diary
Note the product, since naproxen and naproxen sodium appear under different names, and whether any second medicine was taken the same day. Record pain at 2 hours. If naproxen is used with a triptan, a day with both counts once toward any-medicine days, and that total has a limit of 10 days.
Sources
- Naprosyn (naproxen) tablets prescribing information, revised 12/2024
- Naproxen suspension prescribing information
- Aleve (naproxen sodium) label
- Treximet (sumatriptan and naproxen sodium) prescribing information
- Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013, Issue 10
- Cochrane plain language summary: Naproxen for acute migraine in adults
- ICHD-3, 8.2.3 Non-opioid analgesic-overuse headache
Checked against these sources on 2 November 2026. How this page is written and checked